AutoRadAI, an AI-based tool using MRI data, accurately detects extracapsular extension in prostate cancer, enhancing ...

We therefore did not pursue these models further. Fig 1. Predicted cumulative prostate cancer risks for a 45-year-old consultand by (A) father's age at prostate cancer diagnosis, (B) brother's age at ...

When I learned that former President Joe Biden had not undergone prostate-specific antigen (PSA) screening since 2014—and was ...

Annual Meeting held in Chicago, IL, was host to a State of the Science session on novel diagnostics and therapeutics in renal cell and urothelial carcinomas. Dr. Michael Hofman presented an in-depth ...

CEO of Bayer UK & Ireland, Antonio Payano, said: “We are delighted that men with prostate cancer in England will have early access to another innovative treatment option.

A type of hormone therapy known as androgen deprivation therapy (ADT) has long been the backbone of treatment for metastatic prostate cancer. The male sex hormone testosterone (a type of hormone ...

Short-term results of VOLTAGE-A: Nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy in patients with microsatellite stable and microsatellite ...

“They’re pretty good about ruling out prostate cancer,” he says. Biomarker tests may show that you don’t need the next step: a magnetic resonance imaging (MRI) scan. The specialized MRI lets doctors ...

Notably, treatment usage trends from a Bladder Cancer Advocacy Network (BCAN) survey presented at GU ASCO 2025 revealed that only 1–5% of patients reported having seen a radiation oncologist and only ...